Nuria Barbarroja (N Barbarroja)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

Arthritis & rheumatology (Hoboken, N.J.)

Therapeutic advances in musculoskeletal disease

Journal of clinical medicine

Journal of internal medicine

IMIBIC

Reina Sofia Hospital. University of Cordoba (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IMIBIC

Spain

Postdoctoral researcher, Miguel Servet programme :: Rheumatology service

Education History

Reina Sofia Hospital. University of Cordoba - Sep 15 2006

Spain

PHD :: Hematology

University of Cordoba Oct 01 1995 - Sep 23 2000

Spain

BSC

Publications

Carmen Priego-Pérez, María Ángeles Puche-Larrubia, Lourdes Ladehesa-Pineda, Jerusalem Calvo-Guitérrez, Rafaela Ortega-Castro, Alejandro Escudero-Contreras, Nuria Barbarroja, Eduardo Collantes-Estevez, Clementina López Medina
Different Therapeutic Response to Anti-TNF Drugs in Patients with Axial Spondyloarthritis Depending on Their Clinical Profile: An Unsupervised Cluster Analysis. Journal of clinical medicine 13 (7) (2024)
Carmen Priego-Pérez, María Ángeles Puche-Larrubia, Lourdes Ladehesa-Pineda, Jerusalem Calvo-Guitérrez, Rafaela Ortega-Castro, Alejandro Escudero-Contreras, Nuria Barbarroja, Eduardo Collantes-Estevez, Clementina López Medina
Different Therapeutic Response to Anti-TNF Drugs in Patients with Axial Spondyloarthritis Depending on Their Clinical Profile: An Unsupervised Cluster Analysis. Journal of clinical medicine 13 (7) (2024)
Carmen Priego-Pérez, María Ángeles Puche-Larrubia, Lourdes Ladehesa-Pineda, Jerusalem Calvo-Guitérrez, Rafaela Ortega-Castro, Alejandro Escudero-Contreras, Nuria Barbarroja, Eduardo Collantes-Estevez, Clementina López Medina
Different Therapeutic Response to Anti-TNF Drugs in Patients with Axial Spondyloarthritis Depending on Their Clinical Profile: An Unsupervised Cluster Analysis. Journal of clinical medicine 13 (7) (2024)
Carlos Perez-Sanchez, Alejandro Escudero-Contreras, Tomás Cerdó, Luz Marina Sánchez-Mendoza, Adrián Llamas-Urbano, Iván Arias-de la Rosa, Miguel Pérez-Rodriguez, Laura Muñoz-Barrera, María Del Carmen Abalos-Aguilera, Nuria Barbarroja, Jerusalem Calvo, Rafaela Ortega-Castro, Desiree Ruiz-Vilches, Juan Antonio Moreno, María Isabel Burón, José Antonio González-Reyes, Eduardo Collantes-Estevez, Rosario Lopez-Pedrera, José Manuel Villalba
Preclinical characterization of pharmacological NAD + boosting as a promising therapeutic approach in Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Carlos Perez-Sanchez, Alejandro Escudero-Contreras, Tomás Cerdó, Luz Marina Sánchez-Mendoza, Adrián Llamas-Urbano, Iván Arias-de la Rosa, Miguel Pérez-Rodriguez, Laura Muñoz-Barrera, María Del Carmen Abalos-Aguilera, Nuria Barbarroja, Jerusalem Calvo, Rafaela Ortega-Castro, Desiree Ruiz-Vilches, Juan Antonio Moreno, María Isabel Burón, José Antonio González-Reyes, Eduardo Collantes-Estevez, Rosario Lopez-Pedrera, José Manuel Villalba
Preclinical characterization of pharmacological NAD + boosting as a promising therapeutic approach in Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Carlos Perez-Sanchez, Alejandro Escudero-Contreras, Tomás Cerdó, Luz Marina Sánchez-Mendoza, Adrián Llamas-Urbano, Iván Arias-de la Rosa, Miguel Pérez-Rodriguez, Laura Muñoz-Barrera, María Del Carmen Abalos-Aguilera, Nuria Barbarroja, Jerusalem Calvo, Rafaela Ortega-Castro, Desiree Ruiz-Vilches, Juan Antonio Moreno, María Isabel Burón, José Antonio González-Reyes, Eduardo Collantes-Estevez, Rosario Lopez-Pedrera, José Manuel Villalba
Preclinical characterization of pharmacological NAD + boosting as a promising therapeutic approach in Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Ivan Arias de la Rosa, Maria Dolores López-Montilla, Cristobal Román-Rodríguez, Carlos Pérez-Sánchez, Ignacio Gómez-García, Clementina López-Medina, Maria Lourdes Ladehesa-Pineda, Maria Del Carmen Ábalos-Aguilera, Desiree Ruiz, Alejandra Maria Patiño-Trives, Maria Luque-Tévar, Isabel Añón-Oñate, Maria Jose Pérez-Galán, Rocio Guzmán-Ruiz, Maria M Malagón, Rosario Lopez-Pedrera, Alejandro Escudero-Contreras, Eduardo Collantes-Estévez, Nuria Barbarroja
The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast. Journal of internal medicine 291 (5) (2022)
Ignacio Gómez-García, Teresa García-Puga, Pilar Font-Ugalde, María Ángeles Puche-Larrubia, Nuria Barbarroja, Patricia Ruiz-Limón, Alejandro Escudero-Contreras, Eduardo Collantes-Estévez, Clementina López Medina
Relationship between onset of psoriasis and spondyloarthritis symptoms with clinical phenotype and diagnosis: data from REGISPONSER registry. Therapeutic advances in musculoskeletal disease 14 (2022)
Carlos Perez-Sanchez, Nuria Barbarroja, Lucas Carminatti Pantaleão, Laura M López-Sánchez, Susan E Ozanne, Bernabé Jurado-Gámez, Enrique Aranda, Chary Lopez-Pedrera, Antonio Rodríguez-Ariza
Clinical Utility of microRNAs in Exhaled Breath Condensate as Biomarkers for Lung Cancer. Journal of personalized medicine 11 (2) (2021)
Iván Arias de la Rosa, Pilar Font, Alejandro Escudero-Contreras, María Dolores López-Montilla, Carlos Pérez-Sánchez, María Carmen Ábalos-Aguilera, Lourdes Ladehesa-Pineda, Alejandro Ibáñez-Costa, Carmen Torres-Granados, Yolanda Jimenez-Gomez, Alejandra Patiño-Trives, María Luque-Tévar, María Carmen Castro-Villegas, Jerusalem Calvo-Gutiérrez, Rafaela Ortega-Castro, Chary López-Pedrera, Eduardo Collantes-Estévez, Nuria Barbarroja
Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis. Therapeutic advances in chronic disease 11 (2020)
Inmaculada Concepción Aranda-Valera, Iván Arias de la Rosa, Rosa Roldán-Molina, María Del Carmen Ábalos-Aguilera, Carmen Torres-Granados, Alejandra Patiño-Trives, María Luque-Tevar, Alejandro Ibáñez-Costa, Rocío Guzmán-Ruiz, María Del Mar Malagón, Alejandro Escudero-Contreras, Chary López-Pedrera, Eduardo Collantes-Estévez, Nuria Barbarroja
Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission. Pediatric rheumatology online journal 18 (1) (2020)
María Lourdes Ladehesa-Pineda, Iván Arias de la Rosa, Clementina López Medina, María Del Carmen Castro-Villegas, María Del Carmen Ábalos-Aguilera, Rafaela Ortega-Castro, Ignacio Gómez-García, Pedro Seguí-Azpilcueta, Yolanda Jiménez Gómez, Alejandro Escudero-Contreras, Chary López Pedrera, Nuria Barbarroja, Eduardo Collantes-Estévez, null null
Assessment of the relationship between estimated cardiovascular risk and structural damage in patients with axial spondyloarthritis. Therapeutic advances in musculoskeletal disease 12 (2020)
Nuria Barbarroja, Iván Arias-de la Rosa, Clementina López-Medina, María Del Rosario Camacho-Sánchez, Ignacio Gómez-García, Antonio José Vélez-García, Alejandro Escudero-Contreras, Chary López-Pedrera, María Dolores López-Montilla, Eduardo Collantes-Estévez
Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis. Therapeutic advances in musculoskeletal disease 11 (2019)
I Arias de la Rosa, A Escudero-Contreras, S Rodríguez-Cuenca, M Ruiz-Ponce, Y Jiménez-Gómez, P Ruiz-Limón, C Pérez-Sánchez, M C Ábalos-Aguilera, I Cecchi, R Ortega, J Calvo, R Guzmán-Ruiz, M M Malagón, E Collantes-Estevez, A Vidal-Puig, Ch López-Pedrera, Nuria Barbarroja
Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues. Journal of internal medicine 284 (1) (2018)

Nuria Barbarroja.css-eqlu8i{font-size:small;padding-left:4px;} (N Barbarroja)

Publication Activity (10 Years)

Top Topics

Top Venues

Nuria Barbarroja (N Barbarroja)